LXRX Q1 2021 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$704M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27,000-99.7% YoY

Gross Profit

-$13M-46600.0% margin

Operating Income

-$21M-77181.5% margin

Net Income

-$21M-77622.2% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-86.4%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$193M

Total Liabilities

$41M

Stockholders' Equity

$153M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27,000	$8M	-99.7%
Gross Profit	-$13M	$7M	-269.3%
Operating Income	-$21M	-$62M	+66.6%
Net Income	-$21M	-$67M	+68.5%